؉ , Ca ؉ and Zn ؉ cations is clearly disturbed and involved in the development and maintenance of a hypertensive condition. These changes are closely related to each other; therefore, when their effects on primary hypertension (PH) are studied, they should always be globally (and not separately) considered. These changes of the aforementioned electrolytes in PH maintain a close, but unclear, relationship with various hormonal systems, mainly with the reninangiotensin-aldosterone system. Daily control in the intake of these electrolytes (especially Na ؉ and Ca ؉؉ ) remains a cornerstone in the adjuvant treatment of PH. Na ؉ dietary restriction is indicated in hypertensives showing higher sensitivity to salt; in most cases they have low (70%) plasma renin activity (PRA) and belong to one of the following five groups: black, elderly, obese
Introduction
A precise evaluation about the influence of various elements in the daily diet on primary hypertension (PH) is a quite difficult task, because the obtained responses are never so marked as those observed following the administration of different hypotensive drugs. More valuable responses can be obtained using ambulatory monitoring of blood pressure (AMBP), reflecting the influence of a specific diet on the blood pressure (BP) circadian cycle. 1 The study of a higher number of cases (metaanalysis study) is needed to draw more valuable conclusions about this diet-hypertension relationship.
For a long time, different diets have been tested for the treatment of PH. We can cite the Kempner diet 2 -rice without salt, and fruits-used several years ago in very severe hypertension. Later on, most varied diets have been assayed, always with very controversial results.
The DASH study 3 used a diet based on low-fat dairy products, fruits and vegetables, obtaining highly variable results. High fibre diets have also been used. Some authors have reported good results studying other diets with a high content of fish oil (Omega-3) in patients receiving beta-blockers, and they have obtained additional decreases of nocturCorrespondence: Dr José Luis García Zozaya, Service of Nephrology for Adults, 'Dr. Enrique Tejera' Hospital, Carabobo University, Valencia, Venezuela or diabetic (type 2) patients, and mixed blood young people from our community with low levels of PRA and serum ionic calcium. For best results, this moderate Na ؉ restriction (4 -6 g of NaCl) should always be accompanied by an oral calcium supplement, or at least the assurance that the subject takes an appropriate amount of Ca ؉؉ (Ͼ800 mg/day) in his/her diet. Hypertensives with low PRA exhibit obvious changes of their calcium metabolism. We do not know the role of Zn ؉؉ in the development of PH; however, older hypertensives with very low PRA have high urinary excretion of Zn ؉؉ with low serum levels, a factor that could contribute to Zn ؉؉ depletion in these hypertensive patients. The oral administration of calcium corrects the Zn ؉؉ changes by a still unclear mechanism. Journal of Human Hypertension (2000) 14, Suppl 1, S100-S104.
nal BP. 4 The interest in this subject has been particularly focused on various electrolytes included in the daily diet, such as Na + , Ca ++ , K + , Zn ++ and Mg ++ . Highly variable and controversial results have been reported. 5 In this short review, we will discuss specifically the actions of Na + and Ca ++ electrolytes, making a brief reference to Zn ++ cation, their relationships to each other and with the renin-angiotensinaldosterone system (RAAS). With the previously mentioned diets, those successful have been able to reduce BP moderately. It is important to note the publication of the TOMHS study; 6 this showed that the best prevention of cardiovascular complications in mild hypertensives was obtained combining lifestyle (particularly dietary habits) with the simultaneous use of hypotensive drugs. This is the criterion that we will follow in this review, placing the diet in the position it really deserves, as an adjuvant in the treatment of PH.
From the beginning, it is important to realise that the effects of these cations on the development of PH should not be considered separately, because there are very close interrelations among them, with clear reciprocal influences. When discussing the development of a hypertensive condition, we must always consider them globally.
The action of these cations on BP can be considered from several points of view: (a) the ability of their intake restriction to stop or delay the development of PH; (b) the benefit that it might provide as an adjuvant treatment for the patient receiving antihypertensive drugs.
We will present a short review of worldwide medical literature and we will comment on our own S101 experience, reported in several published works conducted in our High Blood Pressure Unit at the 'Dr. Enrique Tejera' Hospital, Valencia, Venezuela.
Role of sodium in the development and maintenance of a hypertensive condition
Changes in sodium excretion play a key role in the pathogenesis of hypertensive conditions. There is a very precise balance between two systems in the kidney: the glomerulotubular balance (Na + -retaining) and a pressure-natriuresis mechanism (Na + -excreting). 7 These mechanisms can be disturbed because of genetic, environmental, ethnic factors, etc, and PH could result. That is the rationale for the study of this cation.
One of the most discussed and controversial points in PH has always been the relationship between sodium intake and increase of blood pressure. Since the report, some years ago, of the INTERSALT study results, 8 a direct sodium intakehypertension relationship could be demonstrated at individual level; on the other side, reducing the Na + intake of the general population is not recommended as an effective method to prevent the development of PH.
The average intake of Na + in developed western countries is 150 mEq/day (evaluated from the study of Na + urinary excretion in 24 h). In our community we have found that between 15 and 60 years of age, the daily urinary sodium excretion was 148 mEq, similar to more developed countries; however, in subjects older than 60 years, the Na + excretion was less than 116 mEq/day. Our elderly people have a lower Na + intake, compared with the values described in other countries (see Table 1 ). 9 We conducted a similar study in normotensive subjects from Patanemo, a village close to our unit but on the seashore and with a clear predominance of black subjects. In this ethnic group we found a daily Na + excretion of 186 mEq, and cases of very severe hypertension with low plasma renin values (2.8 ng/ml/h). UNa + , Na + urinary excretion; PRA, plasma renin activity.
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As we will discuss later on, Na + dietary restriction should not be a generalised indication for all hypertensive subjects, but must be reserved to some groups of hypertensive patients.
This low-sodium diet is useful in sodium-sensitive hypertensives; moreover, it is able to enhance the hypotensive action of some drugs. It is convenient to note that when a low-sodium diet is indicated to a hypertensive, it must be moderate (4 -6 g per day of salt), because no additional advantage is achieved with extreme diets; in contrast, several undesired effects could occur.
In patients receiving angiotensin-converting enzyme (ACE) inhibitors, AT1 receptor blockers or non-dihydropyridine-calcium channels blockers (CCB), the hypotensive action of this drugs is enhanced by a low-salt diet, and also its antiproteinuric effect is increased (microalbuminuria is reduced). 10 When dihydropyridine-CCBs are used, the lowsodium diet does not induce the previously described actions.
Several studies have not been able to show a direct relationship between Na + intake and PH; so, it is believed that other contributing factors to Na + are needed for a response to a low-sodium diet, such as a higher intake of Ca ++ or K + , etc.
Sodium-sensitive hypertensives
There is a group of so-called sodium-sensitive hypertensives, in which a favourable hypotensive response is obtained following sodium restriction in the diet; on the other hand, a high Na + intake increases BP. In these patients, management of sodium overload by the kidney is very poor. In contrast, there is another group of sodium-resistant patients, in whom BP is not changed by reducing the sodium from the diet, and in some cases BP could even rise.
At present, simple, practical tests to safely screen sodium-sensitive and sodium-resistant hypertensives are not available. 11, 12 However, we know that in the global population of hypertensives, four groups have shown higher sensitivity to a high Na + intake: elderly, blacks, obese and type 2-diabetic patients.
It is important to note that women are more sensitive to Na + than men.
Features of sodium-sensitive hypertensives: Sodium-sensitive hypertensives present several characteristic abnormalities:
• low PRA values;
• increased peripheral resistance to insulin;
• higher microalbuminuria values;
• disturbances of Ca ++ and Zn ++ metabolism; • poor intrarrenal production of nitric oxide (NO);
• increased values of atrial natriuretic peptide (ANP); • abnormal sodium co-transportation;
• changes in dopamine renal secretion;
• increased reactivity of the sympathetic nervous system;
• reduced number of functional nephrons.
As can be observed above, several very complex and important abnormalities are present in sodiumsensitive hypertensives. 13 It seems that the most evident changes producing these abnormalities are loss of functional renal mass and inappropriate modulation of RAAS in response to different sodium intakes. These abnormalities include loss of working nephrons, decreased coefficient of glomerular capillary filtration, segmental renal ischaemia and increased reabsorption in the distal tubule and collecting duct. On the other hand, sodium-resistant patients are characterised by normal functional renal mass and good modulation of RAAS in response to salt intake, but they exhibit increased pre-glomerular vascular resistance and increased reabsorption in the proximal tubule and loop of Henle.
Most black, obese, elderly and type-2 diabetic patients are sodium-sensitive (more than 70% present low plasma renin activity (PRA) values) and they constitute a group where a low Na + intake is useful.
14 Sodium-sensitive patients present disturbances of natriuresis, due to inability of the kidney to increase the blood supply in response to a high sodium intake.
RAAS and sodium sensitivity:
In normotensive subjects from our community we have found a very close correlation between PRA and Na + urinary excretion (see Table 1 ); this correlation disappeared when a whole group of hypertensive patients was studied, but it reappeared again, although weaker (P Ͻ 0.05), when only hypertensive subjects with low plasma renin (ie, the group including most of the sodium-sensitive hypertensives) were selected.
Some changes usually observed in patients with established hypertension, such as abnormal tolerance to glucose, increased peripheral resistance to insulin, exaggerated response to vasopressor compounds, and low PRA and serum ionic Ca ++ values, have been described in a group of sodium-sensitive normotensives. 15 We have conducted a very interesting study in two normotensive subpopulations from our community, both of the same age, but one of them with lower PRA and serum ionic calcium values (statistically significant differences). These subjects showed higher systolic BP (high normal) values. We believe that they are in a pre-hypertensive condition and can derive some benefit from a low Na + /high Ca ++ diet to protect them against progression toward hypertension. This group could be located in the sodium-sensitive normotensive population. 16 In clinical practice, the assay of peripheral plasma renin is useful to identify two extreme groups of low-renin and high-renin hypertensives, with quite different pathophysiological features. Most of the sodium-sensitive hypertensives were found in the low-renin group. Tables 2 and 3 exhibit the differences between both groups.
Low-PRA hypertensives show more evident changes in calcium metabolism: increased calcium urinary excretion, low serum ionic calcium and higher parathyroid hormone (PTH). On the other hand, hypertensive subjects with increased PRA present more evident changes in magnesium metabolism: increased urinary excretion and low serum magnesium values. 17 Age and sodium sensitivity: As we get older, electrolytic and hormonal changes are taking place in our body, such as a large decrease of PRA, 'inappropriately' increased plasma aldosterone (PA) levels (physiologic 'hyperaldosteronism' in the elderly), increases of ANP and PTH, reduction of serum ionic calcium (Ca) values and, at the same time, the relationship between RAAS and ANP is lost. 18 Hypertension in older persons is typically a lowrenin hypertension with very specific features (see Table 4 ). 19 Elderly patients show a poor response to l-arginine infusion to increase NO production in the kidney. All these changes become more pronounced following the development of hypertension (see Table 4 ). In 60-year-old normotensive subjects, hormonal and electrolytic changes can be clearly observed. However, we conducted a study in a group of younger hypertensive patients from our S103 clinical practice and we found early development of these hormonal changes (around 45 years of age), resulting in a 'premature elderly' pattern, because their hormonal and electrolytic abnormalities are closer to those observed in older persons than to contemporary normotensives. 20 Age is one of the major determining factors for the response of hypertensives to salt intake; in addition, Na + sensitivity is linked to changes in renal and endocrine function typically found in elderly people. 21 In older persons we can see:
(1) Changes in renal function: reduced amount of nephrons with smaller glomerular filtration area. (2) Endocrine changes: reduced RAAS response to salt intake, increase of circulating NAP.
Relationship between calcium and sodium in high blood pressure
Several reports have shown a close relationship between sodium and calcium metabolism, both in normotensives and in the abnormalities developed when the subject becomes hypertensive. 22, 23 We conducted a study on normotensive subjects in our Unit, measuring Na + and Ca ++ urinary excretion, and we found a very significant correlation: n = 32; r = 0.8949; P Ͻ 0.001. This correlation is maintained in hypertensives, but at a lower level of significance: n = 30; r = 0.4375; P Ͻ 0.05. At similar levels of Na + excretion, higher urinary calcium loss was observed in hypertensives.
Abnormalities in calcium metabolism are clear in elderly hypertensives compared with a normotensive group of the same age (see Table 4 ).
When elderly hypertensive patients received calcium carbonate, 1.5 g/day for 4 weeks, we observed changes in various parameters (see Table 5 ). Elderly normotensive subjects showed the same response to calcium supplements, although the changes were smaller.
Another important finding in these elderly subjects was an increased Zn ++ urinary excretion, already reported by us in low-PRA hypertensive patients. Zn ++ excretion was very high in elderly
Journal of Human Hypertension 24 These changes were also modified by the intake of calcium carbonate. We do not have a clear explanation either for these abnormalities linking Ca ++ and Zn ++ metabolism in elderly hypertensive women with low PRA, or their relationship with hormonal changes present in these patients. From a practical point of view, we can highlight that in elderly subjects (sodium-sensitive with low PRA) their salt intake should be restricted, but also oral calcium supplements should be given, or at least an appropriate dietary calcium allowance (Ͼ800 mg/day) must be assured, in order to achieve an important decrease in their systolic hypertension and to reverse hormonal changes.
In elderly patients receiving a CCB we also observed that when calcium supplements are given simultaneously, the hypotensive action of the CCB is enhanced, and occasionally the CCB dosage should be reduced.
Studies in experimental animals, as well as in humans, have demonstrated that oral calcium administration exhibits a protective action on the hypertensive effect of a high salt intake.
Ackley 25 suggests that the high calcium content of milk derivatives seems to exert a protective effect on the rise of BP values in communities. Garcia Palmieri 26 reports similar results from population studies in Puerto Rico, where the usual diet involves a low calcium intake.
Changes in calcium metabolism have been described when comparing subjects with highnormal and low-normal blood pressure during the first 2 decades of their life, before the appearance of a hypertensive condition. 27 Similarly, in normotensive young people from hypertensive parents, high PTH levels and inconsistencies between calcium and sodium in urine and serum ionic calcium values have been demonstrated. 28 In hypertensive relatives, the administration of a high-calcium/low-sodium results in a significant increase in serum ionic cal-cium and reduces 1,25 (OH) 3 dihydro-calciferol values. 29 Higher reactivity to a high Na + intake and stress has been demonstrated in black subjects with a lowcalcium diet. 30 Usually, African Americans have a low-calcium diet (Ͻ450 mg/d).
Oral calcium supplements in black and type-2 diabetic hypertensive patients are able to reduce vascular resistance and could induce partial regression of left ventricular hypertrophy. 31 We can conclude that, because of the close relationship between Na + and Ca ++ metabolism, these cations should always be considered together in arterial hypertension. In daily clinical practice, when a low-salt diet is indicated, this should be complemented with an oral calcium supplement to obtain the best results. It has been observed that many sodium-sensitive subjects are calciumdepleted.
